IBM, Oracle, Intel join OKX-ICE tokenized stock objections as total hits 26

OKX-ICE is a tokenized-stock venue run jointly by OKX and Intercontinental Exchange, built on the premise that US equities can be wrapped into tradable tokens without the underlying company's sign-off, since SEC rules do not require issuer consent for such products. The objector list, first reported at 22 names on Oct. 23, grew to 26 by the venue's own revised notice dated Oct. 26, now including IBM, Oracle, Intel and IonQ alongside earlier entrants.

Objecting does not stop OKX-ICE from listing a company's tokenized shares; it only puts on record that the company never agreed to it. Holders of these tokens get price exposure without voting rights, dividends routed through the issuer, or any contractual tie to the real stock. For IBM, Oracle and Intel, the public objection is a liability shield and a signal to shareholders that the venue's tokens carry no corporate endorsement.

A tokenized share that trades without the issuer's agreement tests what the product is actually selling: synthetic price exposure dressed as equity ownership. Tokenization was pitched as a way to give investors frictionless, compliant access to real securities, but a model that proceeds over 26 companies' objections inverts that pitch, leaning on a regulatory gap rather than issuer cooperation. That gap, not the technology, is the real story here.

The number to track is whether the objector list keeps climbing past 26 in OKX-ICE's next notice, and whether the SEC moves to close the issuer-consent gap that lets the venue list shares over companies' stated objections. A formal rule change would force OKX-ICE to either drop the 26 tokens or renegotiate consent; silence from the SEC lets the current workaround stand.